Abstract
Autism spectrum disorders (ASD) encompass a diverse range of developmental disabilities characterized by pervasive deficiencies in socialization, communication, and the manifestation of behavioral issues. This review aims to clarify the diagnostic criteria for ASD, explore available diagnostic tools, evaluate biomedical examinations facilitating ASD diagnosis, and discuss the approach to screening assessments for ASD. ASDs are prevalent conditions, with a globally estimated prevalence of 7.6 cases per 100 (one in 132), based on a comprehensive review of epidemiological studies. The precise cause of autism and other ASDs remains unknown; however, genetic and environmental factors likely contribute. Common signs and symptoms shared among individuals with autism include restricted repetitive behaviors and learning disabilities. Standardized methods, such as the Diagnostic and Statistical Manual, Fifth Edition (DSM-5), diagnostic instruments, a thorough medical history, multiple physical examinations, laboratory investigations, neuroimaging, and screening tests, play a pivotal role in early autism diagnosis and intervention. ASD is a lifelong neurodevelopmental condition characterized by multiple deficits. Early detection is anticipated to have a positive impact on outcomes.
Keywords: literature review, screening assessment, biomedical investigations, diagnostic instruments, diagnostic criteria, behavioral problems, communication, socialization, developmental disabilities, autism spectrum disorders
Introduction and background
Autism spectrum disorders (ASD) constitute a complex neurodevelopmental disorder influenced by a spectrum of genetic, pathophysiological, and environmental factors, typically manifesting early in childhood and persisting throughout life [1]. The prevalence of ASD among school-aged children has surged from one in 150 in 2000 to one in 54 in 2016, highlighting its relatively common occurrence [2].
ASD represents a cluster of developmental disabilities characterized by deficits in social communication and the presence of restricted or repetitive interests and behaviors, aligning with the diagnostic criteria outlined in the Diagnostic and Statistical Manual, Fifth Edition (DSM-5) [3]. Research has consistently shown that children diagnosed with ASD often exhibit behavioral problems, including hyperactivity, poor attention, impulsivity, aggression, self-injury, and challenges in understanding social cues such as body language, gestures, and facial expressions. Moreover, these children frequently display unusual responses to sensory stimuli, such as hypersensitivities to light, sound, color, smell, or touch, and may demonstrate a heightened pain threshold [4].
Additionally, children with ASD manifest qualitative abnormalities in motor performance, which, although not part of the primary diagnostic criteria are believed to contribute to their clinical presentation and overall challenges [5,6]. Typically, children with ASD require substantial levels of supervised care, specialized educational resources, and healthcare services [7].
The diagnosis of ASD usually takes place in early childhood through behavioral observations, clinical presentations, or various imaging techniques such as functional MRI and diffusion tensor imaging. Imaging techniques often reveal abnormalities in volume associated with structural connectivity and atypical functionality in the brain. Magnetic resonance spectroscopy (MRS), a method allowing the quantification of various brain metabolites, including N-acetyl-aspartate (NAA), has reported a significant decrease in NAA concentrations in patients with ASD [8].
ASD necessitates a comprehensive, systematic, and structured approach that extends beyond the mere identification of the disorder. The diagnostic assessment provides invaluable insights into the child's strengths and weaknesses, laying the foundation for a well-informed roadmap for treatment [9]. The significance of an early and reliable ASD diagnosis cannot be overstated, as prompt interventions are essential once signs manifest.
Review
Definition
ASD is a complex neurodevelopmental disorder characterized by three primary features: speech delay, challenges in social interaction and communication, and the presence of repetitive behaviors or desires [10]. Beyond these primary symptoms, autistic children may exhibit comorbidities such as learning disabilities, neurological conditions, depression, digestive deficiencies, and insomnia. In 1943, Kanner introduced the term "autism" for the first time [11]. Over the years, the diagnostic framework has undergone expansion to encompass various manifestations of autism. ASD includes autism, Asperger's disorder, autistic disorder, childhood disintegrative disorder, adolescent autism, and general developmental disorder not otherwise specified.
Epidemiology
The prevalence of ASD varies globally, ranging from 0.02% to 3.66% [12]. There is a higher frequency observed in males than females [13].
In different continents, the prevalence of ASD differs, with rates of 0.4% in Asia, 1% in America, 0.5% in Europe, 1% in Africa, and 1.7% in Australia [12]. The Gulf Cooperation Council (GCC) countries show an increasing prevalence of ASD, considering it one of the most common impairments [14]. Specific rates include 29/10,000 in the UAE, 1.4/10,000 in Oman, and 4.3/10,000 in Bahrain [14]. In 2002, Saudi Arabia identified 42,500 cases of autism, along with additional cases that went undiagnosed [15].
A recent systematic review disclosed that the prevalence of ASD in Arabian Gulf countries, including Saudi Arabia, ranged from 1.4 to 29 cases per 10,000 population, notably lower than the rates reported in developed countries (39 to 77 cases per 10,000) due to underdiagnosis [16]. A cross-sectional study involving 205 individuals diagnosed with ASD revealed a male-to-female ratio of 4.9:1. Comorbidities were present in 65% of patients, with attention-deficit hyperactivity disorder (ADHD) being the most prevalent (53%), followed by intellectual disability (8%), epilepsy (2%), and cerebral palsy (2%) [17].
Etiology
The specific cause of ASD remains uncertain, and hypotheses about its origins have evolved over time. While a psychosocial hypothesis linking autism to defective childbearing was once considered, it has been firmly rejected. Current evidence strongly supports the idea that the etiology of ASD is multifactorial, primarily rooted in genetics [18,19].
Family studies emphasize the familial and heritable nature of autism, with siblings of autistic children having a recurrence ratio ranging from 2% to 8%, surpassing that of the general population [20,21]. Twin studies reveal a higher concordance rate in monozygotic twins (90%) compared to dizygotic twins (10%) [21,22]. Previous research has explored the genetic underpinnings of autism through the identification of gene mutations or copy number variations at specific chromosomal locations associated with neurodevelopmental processes in individuals and families [23,24]. Noteworthy genes linked to the causation of autism, such as FOXP2, RAY1/ST7, IMMP2L, and RELN at 7q22-q33, have been recognized [25]. A study conducted by the International Molecular Genetic Study of Autism Consortium, encompassing 99 multiplex families, identified regions related to ASD on six different chromosomes, with chromosome 7 holding particular significance [26].
Various environmental factors are recognized as potential contributors to autism. Epidemiological studies point to prenatal viral infections, including measles, mumps, rubella, chicken pox, varicella-zoster, and cytomegalovirus infections, as contributing factors [27]. Cytomegalovirus, particularly, has been identified as a causative agent leading to enduring neurological impairment, affecting around 10%-20% of newborns when the mother experiences infection during pregnancy [27].
The correlation between maternal age, paternal age, and autism risk has been identified as a significant factor in several studies [28,29]. Sandin et al., in a meta-analysis, found a lower risk for autism (relative risk of 0.76) for mothers under 20 compared to those aged 25-29. Conversely, mothers aged 35 or older had a higher relative risk (1.52) compared to mothers aged 25-29 [30]. Reichenberg et al., in a study based on the population, indicated that the likelihood of autism starts to increase at the age of 30 and continues to rise after reaching the age of 50 [29]. Furthermore, zinc deficiency has been implicated in certain cases, where prolonged deficiency during pregnancy may result in various dysfunctions in embryonic growth, particularly in neurodevelopment [31]. Initial exploration into the relationship between zinc and autism originated from its association with neurodegeneration and dysfunction [32]. Recent studies also propose that the increased risk of ASD is associated with both the uptake of toxic metals and deficiencies in essential elements [33]. Notably, zinc has been observed to interact with β-amyloid and its precursors, which are crucial factors in the brain's degenerative processes [32].
Symptoms and signs of ASD
Social Communication
The early symptoms of ASD often manifest as delays and difficulties in social interaction, yet these signs may be subtle and easily overlooked. The absence of mutual attention, characterized by a failure to demonstrate interest and share a focus of attention, is particularly indicative of ASD [34]. Caregivers should be attentive to the child's consistent lack of response to their name, as this may suggest potential hearing impairment or ASD.
Additionally, stereotypical behaviors, such as insufficient facial expressions, the lack of a social smile, and limited use of gestures (e.g., clapping, smiling, shaking the head, nodding), are frequently observed. Children with ASD may exhibit a diminished understanding of the emotions of others and may be less attuned to the impact of their own attitudes on those around them [35].
Restricted, Repetitive Behaviors, Interests, and Activities
Restricted, repetitive behaviors, interests, and activities are commonly observed in children with ASD. These behaviors may include motor attitudes such as twirling, finger flicking, hand flapping, and headbanging [34]. It is widely acknowledged that children with ASD often engage in the repetitive use of items, such as lining up toys, and the repetitive use of words, specifically stereometric words with constant shape or pattern, as well as restricted echolalia. The term "restricted echolalia" refers to the specific imitation or reproduction of speech, that is repeated shortly after it has been heard [35].
Learning Disabilities
Historically, individuals with severe learning disabilities (defined as an IQ less than 70) were predominantly identified as having autism. Within the spectrum continuum, comorbid learning disorders are estimated to affect nearly 50% of individuals with ASD. These individuals may exhibit an irregular cognitive profile, characterized by significant variations between verbal and non-verbal scores in either direction. It is crucial to note, however, that individuals with "higher" scores in either verbal or non-verbal abilities may not necessarily reflect enhanced social skills or proficiency in daily coping life skills, which are likely to be severely affected [35].
Diagnostic criteria for ASD
Diagnostic criteria and severity level are shown in Table 1 [36].
Table 1. Diagnostic Criteria and Severity Levels for Autism Spectrum Disorder.
ASD, autism spectrum disorder.
Criteria | Symptoms | Severity Level for ASD |
A. Persistent Deficits in Social Communication and Social Interaction | ||
1. Deficits in relationships | Challenges in adapting behavior to different social contexts, difficulties in engaging in imaginative play or forming friendships, lack of interest in interpersonal connections | Level 3: Requiring very substantial support |
2. Deficits in social-emotional reciprocity | Abnormal social approaches, failure of normal back-and-forth conversation, reduced sharing of interests, emotions, or affect, inability to initiate or respond to social interactions | Level 2: Requiring substantial support |
3. Deficits in nonverbal communicative behaviors | Poorly integrated verbal and nonverbal communication, abnormalities in eye contact and body language, deficits in understanding and using gestures, loss of facial expressions and nonverbal communication | Level 1: Requiring support |
B. Restricted, Repetitive Patterns of Behavior, Interests, or Activities | ||
1. Insistence on sameness | Inflexible adherence to routines or ritualized patterns of behavior, extreme distress at minor changes, difficulties with transitions, rigid thinking patterns, greeting rituals, or a need for routine | Level 3: Requiring very substantial support |
2. Stereotyped or repetitive behaviors | Simple motor stereotypes like lining up toys or flipping objects, engaging in echolalia and using idiosyncratic phrases, repetitive motor movements, use of objects, or speech | Level 2: Requiring substantial support |
3. Hyper- or hyporeactivity to sensory input | Apparent indifference to pain or temperature, adverse responses to specific sounds or textures, excessive smelling or touching of objects, visual fascination with lights or movement | Level 1: Requiring support |
4. Highly restricted and fixated interests | Abnormal intensity or focus, strong attachment to or preoccupation with unusual objects, excessively circumscribed or perseverative interests | Level 1: Requiring support |
C. Symptoms in Early Childhood | ||
1. Early caregiver reports | No longer deemed essential | |
2. Early childhood | Approximately age 8 and younger | |
D. Symptoms Limit and Impair Everyday Functioning | ||
1. Minimal rituals and repetitive behaviors (RRBs) impairments | Significant difficulties with functioning due to RRBs, resistance to efforts to disrupt or divert RRBs from fixed interests | Social communication severity: Level 3, restricted interests severity: level 3 |
2. Minimal social impairment | Social communication deficiencies result in noticeable impairments, challenges in facilitating social encounters, and atypical or ineffective reactions to other people's social overtures | Social communication severity: level 1, restricted interests severity: level 1 |
E. Disturbances Not Better Explained | ||
Not better explained by intellectual disability or global developmental delay | Intellectual impairment and ASD may co-occur, and social communication may persist below the predicted average developmental level in comorbid cases |
Diagnostic instruments for ASD
Evaluation of a Child With ASD
The primary objective of the ASD evaluation is to identify effective strategies and care tailored to the child and family. This involves recognizing coexisting conditions and associated developmental issues that could negatively impact the patients and their families [37].
Diagnosing ASD can be challenging; the National Institute for Health and Care Excellence (NICE) offers recommendations on the assessment and treatment of ASD, urging clinicians in the United Kingdom to guarantee that children and adolescents under suspicion of ASD can avail the services of a regional multidisciplinary autism team. This team assumes a pivotal role in offering support and specialized knowledge in the evaluation and creation of profiles for individuals and their families [34].
History
ASD is identified through a thorough examination of developmental history and behavioral observation across settings like school, home, and social care. Documentation should encompass behavior duration, severity, and consequences. Despite consistent characteristics, their expression may vary in different environments. The analysis should consider the child's overall development, medical history, and potential risk factors [38].
Importantly, the absence of other symptoms and signs, such as poor eye contact or social smiling, does not rule out an ASD diagnosis. It is essential to acknowledge that the absence of parental apprehension regarding early development does not automatically imply a standard developmental trajectory [39].
Examination
As part of the evaluation, a comprehensive physical examination is necessary, incorporating a thorough neurological assessment, dysmorphism regulation, scrutiny for neurocutaneous stigma, and a Woods light (ultraviolet light) examination [40]. It is imperative to identify signs of illness, self-harm, and potential ill-treatment during this process.
Laboratory Investigations
ASD is recognized as a developmental neurological disorder, prompting numerous studies to identify potential biomarkers associated with its development.
Elevated whole-blood serotonin, or hyperserotonemia, represents the first identified biomarker in ASD, present in over 25% of affected children [41]. The contribution of the serotonin system to ASD pathophysiology remains incompletely understood, with emerging data from neuroimaging and postmortem samples indicating changes in the brain serotonin system in ASD [41].
Unusual patterns of visual preference, as gauged by eye-tracking, are considered hallmarks; however, their utility as an early biomarker for ASD remains uncertain [42].
Melatonin deficit has been reported in several studies based on plasma or urine samples from individuals with ASD [43].
Identification of small-molecule peptides using blood plasma proteomic profiling and examination of cerebrospinal fluid can reveal modified patterns of proteins/peptides [33].
Proteomic analysis of serum from children with autism has revealed differential expression of apolipoproteins and other components of protein complements [43].
Magnetic Resonance Imaging (MRI)
Structural MRI: The literature on structural MRI in ASD provides significant evidence of volume differences in both gray and white matter, revealing distinct region-specific variations [44]. Examinations of the basal ganglia have revealed an increased size of the caudate in individuals with autism, and this enlargement corresponds with the intensity of repetitive behaviors [44]. Establishing a connection between neuroanatomical observations and behavioral manifestations is essential for understanding the impact of structural alterations on the origins of ASD.
A noteworthy discovery in the literature is the swift expansion of brain volume in early childhood, characterized by an approximately 10% rise, reaching its peak around 2-4 years [44]. This initial phase of accelerated growth is usually followed by a stabilization, evident in both gray and white matter. Research suggests a more pronounced association with the growth of white matter in early childhood, as indicated by meta-analyses conducted by Amaral et al. and Stanfield et al., proposing that age plays a crucial role and this type of enlargement is predominantly observed in young children with ASD [45,46].
The diversity of these observations emphasizes that autism affects both gray and white matter. Recent advancements in technology now allow for a more nuanced assessment of the composition of gray and white matter structures. Specifically, cortical gray matter can be precisely characterized in terms of cortical thickness and surface area, providing a collective estimate of cortical gray matter volume. Cortical thickness serves as an indicator of dendritic arborization and pruning within gray matter or alterations in myelination at the white-gray matter interface. Meanwhile, variations in surface area correspond with the extent of cortical folding or gyrification, believed to be influenced by the division of progenitor cells during embryogenesis in the periventricular region [44]. The analysis of variations in these measurements of cortical gray matter yields crucial insights into early neuroanatomic developmental events in the ASD population.
Functional magnetic resonance imaging (fMRI): fMRI studies uncover distinctive neuroanatomical patterns in ASD. Hyperactivation is observed in subcortical structures, encompassing the bilateral thalamus, bilateral caudate, and the right precuneus, particularly evident during emotional-face processing. In contrast, there is hypoactivation in the hypothalamus during the same emotional-face processing task. Sub-analyses with more homogeneous contrasts confirm and preserve the key findings of the main analysis, emphasizing the hyperactivation in subcortical structures [47].
Notably, abnormalities in subcortical structures, including the amygdala, hypothalamus, and basal ganglia, are intricately linked to atypical emotional-face processing observed in individuals with ASD [47]. These findings shed light on the intricate interplay between neuroanatomical structures and emotional processing in the context of ASD, advancing our understanding of the neural underpinnings of this complex developmental disorder.
Screening Recommendations
Studies have demonstrated that ASD can often be identified at or below 18 months of age, with a more accurate evaluation possible by age 2 [48]. However, conclusive diagnoses may not be reached until later stages, underscoring the potential delay in necessary care for children with ASD. Early diagnosis significantly influences the initiation of effective recovery programs. The American Academy of Pediatrics (AAP) recommends developmental screening at 9, 18, and 30 months during regular well-child visits. Additional screening may be necessary for children at elevated ASD risk or displaying signs, emphasizing the importance of screening all children, particularly those at higher risk due to factors such as preterm birth or having a family history of ASD [48].
Developmental Screening Tools
Various screening tools assist in identifying children with developmental delays, either disorder-specific or covering multiple areas. The CDC does not endorse specific tools, and the list is non-exhaustive, with options for pediatric practices, school systems, and community settings [48].
Types of screening tools: Several developmental screening tools exist, and selected examples include the following.
Communication and Symbolic Behavior Scales (CSBS): A standardized instrument assessing communication and symbolic skills up to the 24-month level. The Infant-Toddler Checklist is a screening tool completed by parents.
Ages and Stages Questionnaires (ASQ): A comprehensive developmental screening tool, consisting of a parent-completed questionnaire with sections tailored to specific age groups, screening across various domains.
Modified Checklist for Autism in Toddlers (M-CHAT): Parent-completed questionnaire identifying children at risk for autism in the general population.
Parents’ Evaluation of Developmental Status (PEDS): An overall developmental screening tool. It is a parent interview form designed to screen for developmental and behavioral issues, utilizing a single response form applicable to all age groups [49].
Prognosis
Behaviors and presentations exhibit temporal variations, showing a tendency for improvement across various domains, though substantial individual variability exists. A majority of individuals necessitate consistent and precise support throughout their lives. While many adults require ongoing full-time assistance, a small percentage of those with higher-functioning ASD (15%) may achieve independence and gain employment [43].
Critical factors influencing outcomes include the severity of behavioral manifestations, cognitive capacities, and verbal abilities. Researchers have reported promising outcomes for individuals undergoing early interventions that emphasize skill development. However, further research is imperative to ascertain whether these early interventions can exert a lasting impact on individuals with ASD [50].
Treatments and interventions
ASD therapies encompass a spectrum of medical, clinical, speech/language, behavioral, physical therapy, supportive, and alternative approaches to medication. In the treatment of children within the target age range for routine ASD screening, behavioral interventions, particularly early comprehensive behavioral and developmental treatments, play a predominant role. These interventions may employ strategies that integrate elements of cognitive-behavioral therapy, parent reinforcement components, and play or interaction-based approaches [50]. Among the various therapeutic approaches, those centered on integrated behavioral analysis present the highest-quality evidence showcasing their impact on cognitive and language outcomes. Implementation of such strategies may occur in a home or school environment, typically demanding a significant time commitment, with certain programs extending up to 40 hours a week [51].
Applied behavior analysis (ABA) is a treatment firmly rooted in learning theories and behavioral conditioning. It utilizes precise intervention objectives paired with positive reinforcement, including verbal praise, tokens, or rewards [52]. An essential element of ABA is the repetition of learning trials. A comprehensive meta-analysis assessing the efficacy of ABA interventions for young children diagnosed with autism demonstrated moderate to substantial positive impacts on intellectual functioning, language development, acquisition of daily living skills, and social functioning [53]. Significantly larger effect sizes were evident in outcomes related to language. Another noteworthy intervention is pivotal response treatment (PRT), which utilizes a more naturalistic behavioral approach focusing on particular skills and motivations, particularly pivotal areas [54]. In a randomized controlled trial, PRT exhibited advantages for functional and adaptive communication skills in 53 children (aged 2 to 6 years) diagnosed with autism and significant language delay [55]. In comparison to ABA, PRT was regarded as more effective in enhancing verbal expressive communication and associated with a diminished occurrence of disruptive behaviors.
Approximately 70% of individuals with autism also experience concurrent mental health conditions, including ADHD, irritability, aggression, as well as mood and anxiety issues [56]. Risperidone and aripiprazole have received FDA approval for addressing irritability associated with ASD, with risperidone approved for children aged at least five years and aripiprazole for those at least six years old [56]. Prolonged studies assessing the effectiveness of risperidone in ASD have demonstrated its efficacy in reducing behavioral symptoms and impulsivity compared to haloperidol. Additionally, a two-month randomized, double-blind, placebo-controlled trial found no significant differences between aripiprazole and risperidone in children and adolescents with ASD and associated behavioral symptoms. This evaluation considered primary outcome measures (ABC scores) and safety measures, including alterations in appetite and weight gain [57].
Conclusions
ASD, characterized by behavioral challenges in social interactions and repetitive patterns of behavior, activities, and interests, is a heterogeneous and enduring neurodevelopmental disorder. The exact etiology of ASD remains elusive, yet evidence strongly points toward a significant hereditary influence. The diagnosis of suspected ASD in children involves a prompt and multidisciplinary procedure, with local pathways facilitating connections to specialized ASD teams. Various diagnostic modalities, including lab investigations and neuroimaging, contribute to the comprehensive assessment of ASD. Screening assumes a pivotal role in the early detection of ASD, with the anticipation that early diagnosis and early intervention can positively influence outcomes. Recognizing and effectively addressing associated morbid conditions is imperative for comprehensive care.
The authors have declared that no competing interests exist.
Author Contributions
Concept and design: Jumana A. Alrehaili, Ruba A. Alrehaili, Reem M. ElKady, Reem M. Alreefi
Acquisition, analysis, or interpretation of data: Jumana A. Alrehaili, Ruba A. Alrehaili, Reem M. ElKady, Reem M. Alreefi
Drafting of the manuscript: Jumana A. Alrehaili, Ruba A. Alrehaili, Reem M. ElKady, Reem M. Alreefi
Critical review of the manuscript for important intellectual content: Jumana A. Alrehaili, Ruba A. Alrehaili, Reem M. ElKady
Supervision: Ruba A. Alrehaili, Reem M. ElKady
References
- 1.Anderson V, Northam E, Wrennall J. London: Routledge; 2017. Developmental Neuropsychology: A Clinical Approach. [Google Scholar]
- 2.Prevalence of autism/ASD among preschool and school-age children in Norway. Özerk K, Cardinal D. Contemp Sch Psychol. 2020;24:419–428. [Google Scholar]
- 3.Diagnostic and statistical manual of mental disorders 5: A quick glance. Vahia VN. Indian J Psychiatry. 2013;55:220–223. doi: 10.4103/0019-5545.117131. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Blood mercury levels in autism spectrum disorder: Is there a threshold level? Geier DA, Audhya T, Kern JK, Geier MR. https://pubmed.ncbi.nlm.nih.gov/20628441/ Acta Neurobiol Exp (Wars) 2010;70:177–186. doi: 10.55782/ane-2010-1789. [DOI] [PubMed] [Google Scholar]
- 5.A comparison of motor delays in young children: Autism spectrum disorder, developmental delay, and developmental concerns. Provost B, Lopez BR, Heimerl S. J Autism Dev Disord. 2007;37:321–328. doi: 10.1007/s10803-006-0170-6. [DOI] [PubMed] [Google Scholar]
- 6.Motor abilities of children and adolescents with a psychiatric condition: A systematic literature review. Damme TV, Simons J, Sabbe B, van West D. World J Psychiatry. 2015;5:315–329. doi: 10.5498/wjp.v5.i3.315. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Epidemiologic patterns of autism spectrum disorder in pediatric inpatients in the United States, 1997-2019. Chihuri S, Blanchard A, DiGuiseppi CG, Li G. J Autism Dev Disord. 2023 doi: 10.1007/s10803-023-06091-7. [DOI] [PubMed] [Google Scholar]
- 8.Review of progress in diagnostic studies of autism spectrum disorder using neuroimaging. Kaur P, Kaur A. Interdiscip Sci. 2023;15:111–130. doi: 10.1007/s12539-022-00548-6. [DOI] [PubMed] [Google Scholar]
- 9.Autism spectrum disorders: An overview on diagnosis and treatment. Brentani H, Paula CS, Bordini D, et al. Braz J Psychiatry. 2013;35 Suppl 1:0–72. doi: 10.1590/1516-4446-2013-S104. [DOI] [PubMed] [Google Scholar]
- 10.Children with autism spectrum disorder and epilepsy. Francis A, Msall M, Obringer E, Kelley K. Pediatr Ann. 2013;42:255–260. doi: 10.3928/00904481-20131122-10. [DOI] [PubMed] [Google Scholar]
- 11.Sowing the seeds of the autism field: Leo Kanner (1943) Blacher J, Christensen L. Intellect Dev Disabil. 2011;49:172–191. doi: 10.1352/1934-9556-49.3.172. [DOI] [PubMed] [Google Scholar]
- 12.The global prevalence of autism spectrum disorder: A comprehensive systematic review and meta-analysis. Salari N, Rasoulpoor S, Rasoulpoor S, et al. Ital J Pediatr. 2022;48:112. doi: 10.1186/s13052-022-01310-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Autistic phenotypes and genetic testing: State-of-the-art for the clinical geneticist. Lintas C, Persico AM. J Med Genet. 2009;46:1–8. doi: 10.1136/jmg.2008.060871. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Systemic review of the epidemiology of autism in Arab Gulf countries. Salhia HO, Al-Nasser LA, Taher LS, Al-Khathaami AM, El-Metwally AA. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727667/ Neurosciences (Riyadh) 2014;19:291–296. [PMC free article] [PubMed] [Google Scholar]
- 15.Autism seems to be increasing worldwide, if not in London. Yazbak FE. BMJ. 2004;328:226–227. doi: 10.1136/bmj.328.7433.226-c. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Saudi expert consensus-based autism spectrum disorder statement: From screening to management. Alenezi S, Alyahya AS, AlKhalifah SM, et al. Children (Basel) 2022;9:1269. doi: 10.3390/children9091269. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Services for children with autism in the Kingdom of Saudi Arabia. Alnemary FM, Aldhalaan HM, Simon-Cereijido G, Alnemary FM. Autism. 2017;21:592–602. doi: 10.1177/1362361316664868. [DOI] [PubMed] [Google Scholar]
- 18.Autism as a strongly genetic disorder: Evidence from a British twin study. Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff E, Yuzda E, Rutter M. Psychol Med. 1995;25:63–77. doi: 10.1017/s0033291700028099. [DOI] [PubMed] [Google Scholar]
- 19.Genotype and natural history in unrelated individuals with phenylketonuria and autistic behavior. Steiner CE, Acosta AX, Guerreiro MM, Marques-de-Faria AP. Arq Neuropsiquiatr. 2007;65:202–205. doi: 10.1590/s0004-282x2007000200003. [DOI] [PubMed] [Google Scholar]
- 20.[Prevalence of pervasive developmental disorders. A review] Lenoir P, Bodier C, Desombre H, Malvy J, Abert B, Ould Taleb M, Sauvage D. Encephale. 2009;35:36–42. doi: 10.1016/j.encep.2007.12.011. [DOI] [PubMed] [Google Scholar]
- 21.The genetics of autism. Muhle R, Trentacoste SV, Rapin I. Pediatrics. 2004;113:0–86. doi: 10.1542/peds.113.5.e472. [DOI] [PubMed] [Google Scholar]
- 22.Behavioral and biological divergence in monozygotic twin pairs discordant for autism phenotypes: A systematic review. Myers L, Pan PY, Remnélius KL, Neufeld J, Marschik PB, Jonsson U, Bölte S. JCPP Adv. 2021;1:0. doi: 10.1111/jcv2.12017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Patterns and rates of exonic de novo mutations in autism spectrum disorders. Neale BM, Kou Y, Liu L, et al. Nature. 2012;485:242–245. doi: 10.1038/nature11011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.De novo gene disruptions in children on the autistic spectrum. Iossifov I, Ronemus M, Levy D, et al. Neuron. 2012;74:285–299. doi: 10.1016/j.neuron.2012.04.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Genetic and epigenetic etiology underlying autism spectrum disorder. Yoon SH, Choi J, Lee WJ, Do JT. J Clin Med. 2020;9:966. doi: 10.3390/jcm9040966. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Prevalence of autism spectrum disorders in a total population sample. Kim YS, Leventhal BL, Koh YJ, et al. Am J Psychiatry. 2011;168:904–912. doi: 10.1176/appi.ajp.2011.10101532. [DOI] [PubMed] [Google Scholar]
- 27.Association between viral infections and risk of autistic disorder: An overview. Shuid AN, Jayusman PA, Shuid N, Ismail J, Kamal Nor N, Mohamed IN. Int J Environ Res Public Health. 2021;18:2817. doi: 10.3390/ijerph18062817. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Maternal and paternal age and risk of autism spectrum disorders. Croen LA, Najjar DV, Fireman B, Grether JK. Arch Pediatr Adolesc Med. 2007;161:334–340. doi: 10.1001/archpedi.161.4.334. [DOI] [PubMed] [Google Scholar]
- 29.Advancing paternal age and autism. Reichenberg A, Gross R, Weiser M, et al. Arch Gen Psychiatry. 2006;63:1026–1032. doi: 10.1001/archpsyc.63.9.1026. [DOI] [PubMed] [Google Scholar]
- 30.Advancing maternal age is associated with increasing risk for autism: A review and meta-analysis. Sandin S, Hultman CM, Kolevzon A, Gross R, MacCabe JH, Reichenberg A. J Am Acad Child Adolesc Psychiatry. 2012;51:477–486. doi: 10.1016/j.jaac.2012.02.018. [DOI] [PubMed] [Google Scholar]
- 31.Zinc intake, status and indices of cognitive function in adults and children: A systematic review and meta-analysis. Warthon-Medina M, Moran VH, Stammers AL, et al. Eur J Clin Nutr. 2015;69:649–661. doi: 10.1038/ejcn.2015.60. [DOI] [PubMed] [Google Scholar]
- 32.Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide. Mantyh PW, Ghilardi JR, Rogers S, DeMaster E, Allen CJ, Stimson ER, Maggio JE. J Neurochem. 1993;61:1171–1174. doi: 10.1111/j.1471-4159.1993.tb03639.x. [DOI] [PubMed] [Google Scholar]
- 33.Fetal and postnatal metal dysregulation in autism. Arora M, Reichenberg A, Willfors C, et al. Nat Commun. 2017;8:15493. doi: 10.1038/ncomms15493. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Diagnosing autism/autism spectrum disorders. Yates K, Le Couteur A. Paediatr Child Health. 2016;26:513–518. [Google Scholar]
- 35.Autism spectrum disorders in Africa: Current challenges in identification, assessment, and treatment: A report on the International Child Neurology Association Meeting on ASD in Africa, Ghana, April 3-5, 2014. Ruparelia K, Abubakar A, Badoe E, et al. J Child Neurol. 2016;31:1018–1026. doi: 10.1177/0883073816635748. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.DSM-5 and autism spectrum disorders (ASDs): An opportunity for identifying ASD subtypes. Grzadzinski R, Huerta M, Lord C. Mol Autism. 2013;4:12. doi: 10.1186/2040-2392-4-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.DSM-5 criteria for autism spectrum disorder maximizes diagnostic sensitivity and specificity in preschool children. Wiggins LD, Rice CE, Barger B, et al. Soc Psychiatry Psychiatr Epidemiol. 2019;54:693–701. doi: 10.1007/s00127-019-01674-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Autism spectrum disorder. Lord C, Elsabbagh M, Baird G, Veenstra-Vanderweele J. Lancet. 2018;392:508–520. doi: 10.1016/S0140-6736(18)31129-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Autism spectrum disorder: Characteristics, associated behaviors, and early intervention. Kodak T, Bergmann S. Pediatr Clin North Am. 2020;67:525–535. doi: 10.1016/j.pcl.2020.02.007. [DOI] [PubMed] [Google Scholar]
- 40.Clinical assessment, genetics, and treatment approaches in autism spectrum disorder (ASD) Genovese A, Butler MG. Int J Mol Sci. 2020;21:4726. doi: 10.3390/ijms21134726. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.The serotonin system in autism spectrum disorder: From biomarker to animal models. Muller CL, Anacker AM, Veenstra-VanderWeele J. Neuroscience. 2016;321:24–41. doi: 10.1016/j.neuroscience.2015.11.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Eye tracking reveals abnormal visual preference for geometric images as an early biomarker of an autism spectrum disorder subtype associated with increased symptom severity. Pierce K, Marinero S, Hazin R, McKenna B, Barnes CC, Malige A. Biol Psychiatry. 2016;79:657–666. doi: 10.1016/j.biopsych.2015.03.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.The serotonin-N-acetylserotonin-melatonin pathway as a biomarker for autism spectrum disorders. Pagan C, Delorme R, Callebert J, et al. Transl Psychiatry. 2014;4:0. doi: 10.1038/tp.2014.120. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Review of neuroimaging in autism spectrum disorders: What have we learned and where we go from here. Anagnostou E, Taylor MJ. Mol Autism. 2011;2:4. doi: 10.1186/2040-2392-2-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Neuroanatomy of autism. Amaral DG, Schumann CM, Nordahl CW. Trends Neurosci. 2008;31:137–145. doi: 10.1016/j.tins.2007.12.005. [DOI] [PubMed] [Google Scholar]
- 46.Towards a neuroanatomy of autism: A systematic review and meta-analysis of structural magnetic resonance imaging studies. Stanfield AC, McIntosh AM, Spencer MD, Philip R, Gaur S, Lawrie SM. Eur Psychiatry. 2008;23:289–299. doi: 10.1016/j.eurpsy.2007.05.006. [DOI] [PubMed] [Google Scholar]
- 47.Neural bases of atypical emotional face processing in autism: A meta-analysis of fMRI studies. Aoki Y, Cortese S, Tansella M. World J Biol Psychiatry. 2015;16:291–300. doi: 10.3109/15622975.2014.957719. [DOI] [PubMed] [Google Scholar]
- 48.A parent-completed developmental questionnaire: Follow up of ex-premature infants. Skellern CY, Rogers Y, O'Callaghan MJ. J Paediatr Child Health. 2001;37:125–129. doi: 10.1046/j.1440-1754.2001.00604.x. [DOI] [PubMed] [Google Scholar]
- 49.Developmental surveillance and screening of infants and young children. Pediatrics. 2001;108:192–196. doi: 10.1542/peds.108.1.192. [DOI] [PubMed] [Google Scholar]
- 50.Autism spectrum disorder: Classification, diagnosis and therapy. Sharma SR, Gonda X, Tarazi FI. Pharmacol Ther. 2018;190:91–104. doi: 10.1016/j.pharmthera.2018.05.007. [DOI] [PubMed] [Google Scholar]
- 51.Psychosocial treatments targeting anxiety and depression in adolescents and adults on the autism spectrum: Review of the latest research and recommended future directions. White SW, Simmons GL, Gotham KO, Conner CM, Smith IC, Beck KB, Mazefsky CA. Curr Psychiatry Rep. 2018;20:82. doi: 10.1007/s11920-018-0949-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Early communication development and intervention for children with autism. Landa R. Ment Retard Dev Disabil Res Rev. 2007;13:16–25. doi: 10.1002/mrdd.20134. [DOI] [PubMed] [Google Scholar]
- 53.Applied behavior analytic intervention for autism in early childhood: Meta-analysis, meta-regression and dose-response meta-analysis of multiple outcomes. Virués-Ortega J. Clin Psychol Rev. 2010;30:387–399. doi: 10.1016/j.cpr.2010.01.008. [DOI] [PubMed] [Google Scholar]
- 54.Teaching reciprocal imitation skills to young children with autism using a naturalistic behavioral approach: Effects on language, pretend play, and joint attention. Ingersoll B, Schreibman L. J Autism Dev Disord. 2006;36:487–505. doi: 10.1007/s10803-006-0089-y. [DOI] [PubMed] [Google Scholar]
- 55.A randomized clinical trial comparison between pivotal response treatment (PRT) and structured applied behavior analysis (ABA) intervention for children with autism. Mohammadzaheri F, Koegel LK, Rezaee M, Rafiee SM. J Autism Dev Disord. 2014;44:2769–2777. doi: 10.1007/s10803-014-2137-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Risperidone in children with autism and serious behavioral problems. McCracken JT, McGough J, Shah B, et al. N Engl J Med. 2002;347:314–321. doi: 10.1056/NEJMoa013171. [DOI] [PubMed] [Google Scholar]
- 57.A head-to-head comparison of aripiprazole and risperidone for safety and treating autistic disorders, a randomized double blind clinical trial. Ghanizadeh A, Sahraeizadeh A, Berk M. Child Psychiatry Hum Dev. 2014;45:185–192. doi: 10.1007/s10578-013-0390-x. [DOI] [PubMed] [Google Scholar]